Results 231 to 240 of about 4,117,595 (303)

From Material to Medicine: Translational Frontiers in Dosage Form Design for Oral Administration. [PDF]

Pharmaceutics
Abdelhakim HE, Awad A.
europepmc   +1 more source

Oral Nanomicelle‐Mediated Sequential Butyrate Production in the Intestine for Ulcerative Colitis and Immunosuppression Treatment

Advanced Science, EarlyView.
After oral administration, inodorous GLU‐BA self‐assembles into nanomicelles in aqueous environments to resist premature gastric adsorption. Upon reaching the intestine, endogenous esterases rapidly cleave the built‐in ester bonds in these nanomicelles to release BA and GLU, with GLU further metabolized by gut microbiota to gradually generate BA ...
Feifei Xin, Zhike Xie, Danyue Zhao, Lin Yang, Yiqun Wan, Zuwei Liu, Situ Xiong, Ying Zhang, Lei Feng, Hao Wan   +9 more
wiley   +1 more source

Residue depletion and withdrawal period determination of fluralaner in edible tissues and eggs following oral administration in laying Hens. [PDF]

Poult Sci
Chen T, Wang L, Zhang Y, Zhang M, Chen Z, Zhang S, Lang F, Hao Z.   +7 more
europepmc   +1 more source

Trigeminal neuroplasticity after pulpitis and oral administration ofparacetamol in rats. [PDF]

Acta Odontol Latinoam
Canzobre MC, Boix Y, Miyashiro ME, Paganelli AR, Caltana LR, Ríos H.   +5 more
europepmc   +1 more source

Oral administration of <i>Enterococcus lactis</i> strain SF68 speeds the recovery of amoxicillin-clavulanate-induced dysbiosis in cats. [PDF]

J Feline Med Surg
Slaughter M, Sung CH, Suchodolski J, Pilla R, Torres-Hendersen C, Lappin MR.   +5 more
europepmc   +1 more source

Oral administration of <i>Lactiplantibacillus plantarum</i> displaying multiple ASFV antigen proteins on the surface induces systemic immune responses in mice. [PDF]

Appl Environ Microbiol
Fan S, Cheng M, Wen L, Hu A, Zou B, Niu T, Liu M, Jiang Y, Sun Y, Bao M, Wang N, Chen H, Shi C, Wang C.   +13 more
europepmc   +1 more source

Safety, pharmacokinetic, and pharmacodynamic characteristics of SK-08, a soluble guanylate cyclase activator, after oral administration in healthy participants: a randomized phase 1 trial. [PDF]

BMC Nephrol
Liu J, Du Y, Zhou H, Jia H, Zhai Y, Ruan J, Yan C, Xu N, Xin Y, Zheng L, Song Y, Jiang D, Yang J.   +12 more
europepmc   +1 more source

Using a planetary health lens to quantify intravenous use of bioequivalent antimicrobials when oral administration is feasible. [PDF]

J Assoc Med Microbiol Infect Dis Can
MacLaren M, Thalakada R, Zhu H, Lau TT, Shajari S, Bi X, Peermohamed S.   +6 more
europepmc   +1 more source